Medcura, Inc.

New Filing
CIK: 0001672180·Biotechnology·DELAWARE·Filed: Jul 25, 2025
Total Offering

$38,286,410

Amount Sold

$28,548,588

Investors

174

First Sale

Apr 16, 2025

Offering Details

Type
Equity, Other: Convertible Promissory Notes; Series B Preferred Stock underlying the convertible promissory notes
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Jim Buck
Related Person
Larry Tiffany
Related Person
Matthew Dowling, Ph.D
Related Person
Rich Vincent
Related Person
Abbas Ardehali, M.D.
Related Person

Company

Medcura, Inc.

5650 RIVERTECH COURT, SUITE S

RIVERDALE, MD, 20737

3014053585

SEC Filing

0000929638-25-002712

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free